Overexpression of Fli-1 is Associated with Adverse Prognosis of Endometrial Cancer

REFERENCES

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–2917.
   PubMed Web of Science ®Google Scholar
• Engelsen IB, Akslen LA, Salvesen HB. Biologic markers in endometrial cancer treatment. APMIS 2009;117:693–707.
   PubMed Web of Science ®Google Scholar
• Ben-David Y, Giddens EG, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Devel 1991;5:908–918.
   PubMed Web of Science ®Google Scholar
• Melet F, Motro B, Rossi DJ, Zhang L, Bernstein A. Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia. Mol Cell Biol 1996;16:2708–2718.
   PubMed Web of Science ®Google Scholar
• Hewett PW, Nishi K, Daft EL, Clifford Murray J. Selective expression of erg isoforms in human endothelial cells. Int J Biochem Cell Biol 2001;33:347–355.
   PubMed Web of Science ®Google Scholar
• Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006;54:385–395.
   PubMed Web of Science ®Google Scholar
• Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc Natl Acad Sci U.S.A 1990;87:1332–1336.
   PubMed Web of Science ®Google Scholar
• Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992;359:162–165.
   PubMed Web of Science ®Google Scholar
• Kornblau SM, Qiu YH, Zhang N, Singh N, Faderl S, Ferrajoli A, York H, Qutub AA, Coombes KR, Watson DK. Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia. Blood 2011;118:5604–5612.
   PubMed Web of Science ®Google Scholar
• Yi H, Fujimura Y, Ouchida M, Prasad DD, Rao VN, Reddy ES. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Oncogene 1997;14:1259–1268.
   PubMed Web of Science ®Google Scholar
• Pereira R, Quang CT, Lesault I, Dolznig H, Beug H, Ghysdael J. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene 1999;18:1597–1608.
   PubMed Web of Science ®Google Scholar
• Peter M, Magdelenat H, Michon J, Melot T, Oberlin O, Zucker JM, Thomas G, Delattre O. Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;72:96–100.
   PubMed Web of Science ®Google Scholar
• Tamir A, Howard J, Higgins RR, Li YJ, Berger L, Zacksenhaus E, Reis M, Ben-David Y. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol 1999;19:4452–4464.
   PubMed Web of Science ®Google Scholar
• Athanasiou M, Mavrothalassitis G, Sun-Hoffman L, Blair DG. FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. Leukemia 2000;14:439–445.
   PubMed Web of Science ®Google Scholar
• Lennard Richard ML, Nowling TK, Brandon D, Watson DK, Zhang XK. Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation. Mol Immunol 2015;63:566–73.
   PubMed Web of Science ®Google Scholar
• Mhawech-Fauceglia P, Herrmann FR, Bshara W, Odunsi K, Terracciano L, Sauter G, Cheney RT, Groth J, Penetrante R, Mhawech-Fauceglia P. Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody. J Clin Pathol 2007;60:694–700.
   PubMed Web of Science ®Google Scholar
• Sakurai T, Kondoh N, Arai M, Hamada J, Yamada T, Kihara-Negishi F, Izawa T, Ohno H, Yamamoto M, Oikawa T. Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy. Cancer Sci 2007;98:1775–1784.
   PubMed Web of Science ®Google Scholar
• Zhang J, Guo H, Zhang H, Wang H, Qian G, Fan X, Hoffman AR, Hu JF, Ge S. Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer 2011;117:86–95.
   PubMed Web of Science ®Google Scholar
• Song W, Hu L, Li W, Wang G, Li Y, Yan L, Li A1, Cui J. Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer. BMC Cancer 2014;14:424.
   PubMed Web of Science ®Google Scholar
• Elzi DJ, Song M, Hakala K, Weintraub ST, Shiio Y.Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover. J Proteome Res 2014;13: 3783–3791
   PubMed Web of Science ®Google Scholar
• Mills AM, Longacre TA. Endometrial hyperplasia. Semin Diagn Pathol 2010;27:199–214.
   PubMed Web of Science ®Google Scholar
• Masciullo V, Amadio G, Lo Russo D, Raimondo I, Giordano A, Scambia G. Controversies in the management of endometrial cancer. Obstet Gynecol Int 2010;638165.
   PubMedGoogle Scholar
• Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 1985;56:403–412.
   PubMed Web of Science ®Google Scholar
• Pecorelli S, Benedet JL, Creasman WT, Shepherd JH. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet 1999;65:243–249.
   PubMed Web of Science ®Google Scholar
• Liang X, Shi D, Yun J, Mao Y, Ouyang P, Su Z, Fu J, Hou J, Deng W, Xie F Friend leukemia virus integration 1 expression has prognostic significance in nasopharyngeal carcinoma. Transl Oncol 2014;7:493–502.
   PubMed Web of Science ®Google Scholar
• Jia L, Liu Y, Yi X, Miron A, Crum CP, Kong B, Zheng W. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial carcinoma. Clin Cancer Res 2008;14:2263–2269.
   PubMed Web of Science ®Google Scholar
• Niwa K, Murase T, Morishita S, Hashimoto M, Itoh N, Tamaya T. p53 overexpression and mutation in endometrial carcinoma: inverted relation with estrogen and progesterone receptor status. Cancer Detect Prev 1999;23:147–154.
   PubMedGoogle Scholar
• Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR. Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 1992;52:1622–1627.
   PubMed Web of Science ®Google Scholar
• Amandine HL, Truong, David Cervi1, Jane Lee and Yaacov Ben-David. Direct transcriptional regulation of MDM2 by Fli-1. Oncogene 2005;24:962–969.
   PubMed Web of Science ®Google Scholar